Roland Sonntag

2.2k total citations
48 papers, 1.5k citations indexed

About

Roland Sonntag is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Roland Sonntag has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Roland Sonntag's work include Testicular diseases and treatments (9 papers), Liver physiology and pathology (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Roland Sonntag is often cited by papers focused on Testicular diseases and treatments (9 papers), Liver physiology and pathology (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Roland Sonntag collaborates with scholars based in Switzerland, Germany and United States. Roland Sonntag's co-authors include Urs E. Studer, Kurt Brunner, Rainer Kraft, Christian Trautwein, Luca Mazzucchelli, H. J. Senn, Franco Cavalli, Christian Liedtke, Martin F. Fey and Regula Markwalder and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Hepatology and Cancer.

In The Last Decade

Roland Sonntag

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roland Sonntag Switzerland 20 732 485 471 422 286 48 1.5k
Ryo Wada Japan 20 416 0.6× 225 0.5× 437 0.9× 321 0.8× 194 0.7× 140 1.2k
Fujitsugu Matsubara Japan 21 428 0.6× 274 0.6× 484 1.0× 271 0.6× 180 0.6× 83 1.3k
Irshad Soomro United Kingdom 19 509 0.7× 262 0.5× 297 0.6× 643 1.5× 144 0.5× 63 1.3k
Masayuki Itabashi Japan 28 1.4k 1.9× 601 1.2× 832 1.8× 1.3k 3.1× 156 0.5× 96 2.7k
J.Y. Scoazec France 16 214 0.3× 425 0.9× 450 1.0× 145 0.3× 347 1.2× 35 1.2k
Paulette Mhawech Switzerland 19 335 0.5× 442 0.9× 247 0.5× 176 0.4× 110 0.4× 33 1.2k
Jae Ho Han South Korea 28 402 0.5× 448 0.9× 509 1.1× 383 0.9× 132 0.5× 88 1.5k
R. J. Amato United States 20 816 1.1× 779 1.6× 588 1.2× 943 2.2× 149 0.5× 68 2.0k
Robert P. Huben United States 24 870 1.2× 351 0.7× 397 0.8× 894 2.1× 84 0.3× 79 2.0k
Zhen Huo China 21 480 0.7× 460 0.9× 651 1.4× 469 1.1× 183 0.6× 105 1.5k

Countries citing papers authored by Roland Sonntag

Since Specialization
Citations

This map shows the geographic impact of Roland Sonntag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Sonntag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Sonntag more than expected).

Fields of papers citing papers by Roland Sonntag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Sonntag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Sonntag. The network helps show where Roland Sonntag may publish in the future.

Co-authorship network of co-authors of Roland Sonntag

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Sonntag. A scholar is included among the top collaborators of Roland Sonntag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Sonntag. Roland Sonntag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hundertmark, Jana, Tobias Otto, Hilmar Berger, et al.. (2023). Expression of Cyclin E1 in hepatic stellate cells is critical for the induction and progression of liver fibrosis and hepatocellular carcinoma in mice. Cell Death and Disease. 14(8). 549–549. 10 indexed citations
2.
Abdallah, Ali T., Lin Gan, Shelley M. Herbrich, et al.. (2023). Insight into the mechanism of AML del(9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPα) and SPI1 (PU.1). Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1867(1). 195004–195004. 2 indexed citations
3.
Hao, Fengjie, Francisco Javier Cubero, Pierluigi Ramadori, et al.. (2017). Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice. Cell Death and Disease. 8(10). e3152–e3152. 42 indexed citations
4.
Mohs, Antje, Johanna Reißing, Henning W. Zimmermann, et al.. (2016). Functional role of CCL5/RANTES for HCC progression during chronic liver disease. Journal of Hepatology. 66(4). 743–753. 74 indexed citations
5.
Freimuth, Julia, Daniela Lambertz, Wei Hu, et al.. (2013). Loss of caspase-8 in hepatocytes accelerates the onset of liver regeneration in mice through premature nuclear factor kappa B activation. Hepatology. 58(5). 1779–1789. 24 indexed citations
6.
Burkhard, Fiona C., et al.. (2001). FERTILITY AND SEXUAL FUNCTION FOLLOWING ORCHIECTOMY AND 2 CYCLES OF CHEMOTHERAPY FOR STAGE I HIGH RISK NONSEMINOMATOUS GERM CELL CANCER. The Journal of Urology. 165(2). 441–444. 45 indexed citations
7.
8.
Mazzucchelli, Luca, M. Bacchi, Urs E. Studer, et al.. (1994). Invasion depth is the most important prognostic factor for transitional‐cell carcinoma in a prospective trial of radical cystectomy and adjuvant chemotherapy. International Journal of Cancer. 57(1). 15–20. 19 indexed citations
9.
Studer, Urs E., Martin F. Fey, Antonello Calderoni, et al.. (1993). Adjuvant Chemotherapy afterOrchiectomy in High-Risk Patientswith Clinical Stage INon-SeminomatousTesticular Cancer. European Urology. 23(4). 444–449. 39 indexed citations
10.
Harstrick, A., Hans‐Joachim Schmoll, Carsten Bokemeyer, et al.. (1991). Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinoma. Journal of Cancer Research and Clinical Oncology. 117(S4). S198–S202. 3 indexed citations
11.
Joss, R, et al.. (1981). [Chemotherapy of non-small-cell bronchial cancer with a combination of Cis-diamminedichloroplatinum (II) and VP 16-213].. PubMed. 111(36). 1331–4. 3 indexed citations
12.
Brunner, Kurt, Aron Goldhirsch, R Joss, Roland Sonntag, & L Tschopp. (1981). [Results of, and indications for adjuvant chemotherapy in breast cancer].. PubMed. 111(23). 838–45. 1 indexed citations
13.
Sonntag, Roland. (1979). Cis-Diaminodichloroplatin (II) Eine neue Art von Zytostatikum. Onkologie. 2(3). 129–133. 1 indexed citations
14.
Cavalli, F., et al.. (1978). [Bladder carcinoma associated with long-term treatment with cyclophosphamide for multiple myeloma (author's transl)].. PubMed. 17(2). 105–8. 4 indexed citations
15.
Cavalli, F., et al.. (1978). Die Kombination von Adriamycin undcis-Diamino-dichloro-platin (II) in der Behandlung therapieresistenter, fortgeschrittener Ovarialkarzinome. DMW - Deutsche Medizinische Wochenschrift. 103(22). 927–931. 5 indexed citations
16.
Cavalli, F., et al.. (1978). Non-Hodgkin’s Lymphoma Terminating in Acute Myelogenous Leukemia. Acta Haematologica. 60(4). 250–256. 8 indexed citations
17.
18.
Cavalli, F, Roland Sonntag, & Kurt Brunner. (1977). ACUTE LEUKAEMIA IN HODGKIN'S DISEASE. Scandinavian Journal of Haematology. 19(3). 319–320. 5 indexed citations
19.
Sonntag, Roland, et al.. (1975). Treatment of metastatic testicular carcinoma with bleomycin (NSC-125066) used alone or in combination with CCNU (NSC-79037).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 59(2 Pt 1). 429–31. 5 indexed citations
20.
Sonntag, Roland, et al.. (1974). Experience with 4′-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosis. European Journal of Cancer (1965). 10(2). 93–98. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryo Wada Breakdown of academic impact, for papers by Fujitsugu Matsubara Breakdown of academic impact, for papers by Irshad Soomro Breakdown of academic impact, for papers by Masayuki Itabashi Breakdown of academic impact, for papers by J.Y. Scoazec Breakdown of academic impact, for papers by Paulette Mhawech Breakdown of academic impact, for papers by Jae Ho Han Breakdown of academic impact, for papers by R. J. Amato Breakdown of academic impact, for papers by Robert P. Huben Breakdown of academic impact, for papers by Zhen Huo
Rankless by CCL
2026